Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Taltirelin Tablets in Spinocerebellar Ataxia
ChiCTR2500104304Phase 3Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jun 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in spinocerebellar ataxia (SCA) comparing Taltirelin arm with Placebo arm (2 arms). Primary endpoint: Change in total SARA score at Week 28. Started Jun 2025; status: recruiting.
02
Drugs
taltirelin
03
Conditions
spinocerebellar ataxia (SCA)
Beyond the preview
Go deeper on ChiCTR2500104304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104304.